Drug · DIN 02014041

CLINIMIX E

4.25 % AMINO ACIDS (BLEND B) WITH ELECTROLYTES IN 25% DEXTROSE INJECTION

No: no longer authorized

The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.

Status Cancelled Post Market since June 28, 2018; first marketed December 31, 1993.

Active ingredients

As listed in the Drug Product Database.

Ingredient	Strength	Per
DEXTROSE	25 G	100 ML
L-LEUCINE HYDROCHLORIDE	263 MG	100 ML
L-PHENYLALANINE HYDROCHLORIDE	263 MG	100 ML
L-LYSINE HYDROCHLORIDE	246 MG	100 ML
METHIONINE	246 MG	100 ML
L-ALANINE	880 MG	100 ML
GLYCINE	880 MG	100 ML
L-ARGININE	440 MG	100 ML
L-ISOLEUCINE	203 MG	100 ML
L-VALINE	195 MG	100 ML
HISTIDINE	186 MG	100 ML
L-THREONINE	178 MG	100 ML
TRYPTOPHAN	76 MG	100 ML
L-PROLINE	178 MG	100 ML
L-TYROSINE	17 MG	100 ML
SODIUM ACETATE	297 MG	100 ML
POTASSIUM PHOSPHATE DIBASIC	261 MG	100 ML
SODIUM CHLORIDE	77 MG	100 ML
MAGNESIUM CHLORIDE	51 MG	100 ML

Health Canada approvals that name this DIN.

October 31, 2013: NOC 14869New Drug Submission (NDS) · Manufacturer and product name change
October 17, 2003: NOC 435Supplement to a New Drug Submission (SNDS) · Product name change from travasol amino acid injection with electrolytes in dextrose quickmix